This year has been one for the books in medicine. From Ozempic’s expanded role in protecting failing kidneys to long‑acting ...

By shutting South Africa out of its overseas funding for the roll-out of the revolutionary six-monthly HIV prevention jab ...

Source: 46 000 high – risk individuals to receive long acting HIV prevention drug | The Herald (Top Stories) Rumbidzayi Zinyuke recently in Accra, Ghana A TOTAL of 46 500 people will be put on the ...

This study investigates how the HIV inhibitor lenacapavir influences capsid mechanics and interactions with the nuclear pore complex. It provides important insights into how drug-induced ...

The NHI is designed to advance South Africa’s progress toward Universal Health Coverage by ensuring equitable access to ...

The U.S. and Eswatini have entered a five-year health cooperation agreement involving a $242 million understanding to enhance ...

The U.S. and Eswatini signed a five-year health cooperation agreement on Friday, the State Department said, as the Trump administration continues its global health plan to provide aid while requiring ...

Guyana intends to purchase lenacapavir, an anti-retroviral that scientists say can offer protection against the HIV (human ...

The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that ...

In a new brief report, researchers caution against repeating past mistakes in HIV prevention, as high drug prices and insurance coverage issues have slowed uptake of long-acting, bimonthly injectable ...

ACCRA/GENEVA, 10 December 2025 —African leaders can put the continent back on track to end AIDS by 2030 by choosing to ...